СПИСОК ЛИТЕРАТУРЫ

1. Gavrilov, G.B., Tekhnologiya membrannykh protsessov pererabotki molochnoi syvorotki i sozdanie produktov s funktsional’nymi svoistvami (Technology of Membrane Whey Processing and Creation of Products with Functional Properties), Moscow: Rossel’khozakademiya, 2006.
2. Voskuijl, W, de Lorijn, F, Verwijs, W, et al., PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial, Gut, 2004, vol. 53, no. 11, pp. 1590‒1594.
3. Petuely, F., Bifidusflora bei Flaschenkindern durch bifidogene Substanzen (Bifidusfactor), Z. Kinderheimkd, 1957, vol. 79, no. 2, pp.174‒179.
4. Shukla, S., Shukla, A., Mehboob, S., and Guha, S., Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy, Alimentary Pharmacology & Therapeutics, 2011, vol. 33, no. 6, pp. 662‒671.
5. Khramtsov, A.G., Brykalov, B.A., and Kharitonov, D.V., Lactuloza: tsennost’, ispol’zovanie, marketing i effektivnost’ proizvodstva (Lactulose: Value, Application, Marketing, and Production Efficiency), Stavropol: Argus, 2004.
6. US Patent 41 422 916, 1979.
7. Jpn. Patent 52-21 063, 1972.
8. FRG Patent 2 224 680, 1972.
9. US Patent 3 716 408, 1971.
10. Jpn. Patent 56-39 200, 1981.
11. US Patent 4 605 646, 1986.
12. US Patent 5 644 050, 1993.
13. US Patent 5 415 695, 1988.
14. US Patent 5 480 491, 1993.
15. US Patent 5 688 521, 1994.